References
- Wofsy D. Treatment of autoimmune diseases with monoclonal antibodies. Monoclonal Antibody Therapy, H. Waldmann. Karger, BaselSwitzerland 1988; 106–120
- Casali P., Notkins A. L. CD5+ lymphocytes, polyreactive antibodies and the human B-cell repertoire Immunol. Today 1989; 10: 364–368
- Steinman L. Therapy of autoimmune disease with monoclonal antibodies to class II gene products of the major histocompatibility complex. Monoclonal Antibody Therapy, H. Waldmann. Karger, BaselSwitzerland 1988; 161–167
- Rosenbaum J. T., Adelman N. E., McDevitt H. O. In vivo effects of antibodies to IR gene products. I. Haplotype specific suppression of humoral immune responses with monoclonal anti-I-A. J. Exp. Med. 1981; 154: 1694–1699
- Unkeless J. C. Function and heterogeneity of human Fc receptors for immunoglobulin G. J. Clin. Invest. 1989; 83: 355–361
- Waldmann H., Hale G., Clark M., Cobbold S., Benjamin R., Friend P., Bindon C., Dyer M., Qin S., Bruggemann M., Tighe H. Monoclonal antibodies for immune-suppression. Monoclonal Antibody Therapy, H. Waldmann. Karger, BaselSwitzerland 1988; 16–30
- Jonker M. Immunosuppressive therapy by monoclonal anti-T lymphocyte subset antibodies. Leucocyte typing III, A. J. McMichael. Oxford University Press, OxfordUK 1987; 923–927
- Norman D. J. An overview of the use of the monoclonal antibody OKT3 in renal transplantation. Transpl. Proc. 1988; 20: 1248–1252
- Soulillou J. P., Peyronnet P., Le Mauff B., Hourmant M., Olive D., Mawas C., Delaage M., Hirn M., Jacques Y. Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2. Lancet 1987; 1: 1339–1342
- Olsnes S., Sandvig K., Petersen O. W., Van Deurs B. Immuno-toxins-entry into cells and mechanisms of action. Immunol. Today 1989; 10: 291–295
- Clark M., Gilliland L., Waldmann H. Hybrid antibodies for therapy. Monoclonal Antibody Therapy, H. Waldmann. Karger, BaselSwitzerland 1988; 31–49
- Riechmann L., Clark M., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature 1988; 332: 323–327
- Brüggemann M., Neuberger M. S. Novel antibodies by DNA manipulation. Monoclonal Antibody Therapy, H. Waldmann. Karger, BaselSwitzerland 1988; 91–105
- Ward S. E., Güssow D., Griffiths A. D., Jones P. T., Winter G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 1989; 341: 544–546